Journal of Computer-Aided Molecular Design

, Volume 23, Issue 4, pp 195–198

ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI)

Warr's Piece

References

  1. 1.
    ChEMBL http://www.ebi.ac.uk/chembl/. Accessed November 2008
  2. 2.
    Overington JP, Al-Lazikani B, Hopkins AL (2006)) Nat Rev Drug Discov 5:993. doi:10.1038/nrd2199 CrossRefGoogle Scholar
  3. 3.
    Agüero F, Al-Lazikani B, Aslett M, Berriman M, Buckner FS, Campbell RK et al (2008) Nat Rev Drug Discov 7:900. doi:10.1038/nrd2684 CrossRefGoogle Scholar
  4. 4.
    ChEBI http://www.ebi.ac.uk/chebi/. Accessed November 2008
  5. 5.
    Steinbeck C, Han Y, Kuhn S, Horlacher O, Luttmann E, Willighagen E (2003) J Chem Inf Comput Sci 43:493. doi:10.1021/ci025584y Google Scholar
  6. 6.
    Steinbeck C, Hoppe C, Kuhn S, Floris M, Guha R, Willighagen EL (2006) Curr Pharm Des 12:2111. doi:10.2174/138161206777585274 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.Wendy Warr & AssociatesCheshireUK

Personalised recommendations